Global Bacteriophage Market Growth (Status and Outlook) 2024-2030

Global Bacteriophage Market Growth (Status and Outlook) 2024-2030

Product Code:1176506

Published Date: Apr 28,2024

Pages: 137

Region: Global

Category: Pharma & Healthcare

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.

The global Bacteriophage market size is projected to grow from US$ 51.2 million in 2024 to US$ 153 million in 2030; it is expected to grow at a CAGR of 20.0% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Bacteriophage Industry Forecast” looks at past sales and reviews total world Bacteriophage sales in 2022, providing a comprehensive analysis by region and market sector of projected Bacteriophage sales for 2023 through 2029. With Bacteriophage sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bacteriophage industry.

This Insight Report provides a comprehensive analysis of the global Bacteriophage landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Bacteriophage portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bacteriophage market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bacteriophage and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bacteriophage.

Global key players of bacteriophage include NPO Microgen, Qingdao Phagepharm Bio-tech, Armata Pharmaceuticals, Inc., etc. The top three players hold a share about 34%. Europe is the largest market, has a share about 48%. In terms of product type, DsDNA Bacteriophage is the largest segment, occupied for a share of 91%. In terms of application, Animal Health has a share about 51 percent.

This report presents a comprehensive overview, market shares, and growth opportunities of Bacteriophage market by product type, application, key players and key regions and countries.

Segmentation by Type:
    DsDNA Bacteriophage
    SsDNA Bacteriophage
    SsRNA Bacteriophage
    Others

Segmentation by Application:
    Animal Health
    Aquaculture
    Agriculture
    Food Industry
    Human Health
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

Segmentation by Type:
    DsDNA Bacteriophage
    SsDNA Bacteriophage
    SsRNA Bacteriophage
    Others

Segmentation by Application:
    Animal Health
    Aquaculture
    Agriculture
    Food Industry
    Human Health
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    NPO Microgen
    Qingdao Phagepharm Bio-tech
    Armata Pharmaceuticals, Inc.
    Phaxiam Therapeutics
    Eliava BioPreparations
    Intralytix
    MicroMir
    Phagelux
    Pharmex Group, LLC
    APS Biocontrol Ltd. (APS)
    ACD Pharma
    Proteon Pharmaceuticals
    Micreos
    Locus Biosciences, Inc
    NexaBiome Limited
    PhagePro
    BiomX
    INtODEWORLD, Inc.
    TechnoPhage